APGE | Apogee Therapeutics, Inc. Annual & Quarterly Income

Annual Income Statements

(In USD)

Breakdown	2023	2022
Revenue	-	-
Cost of Revenue	-	-
Gross Profit	-	-
Operating Expenses	93 Million	30.72 Million
Selling, General and Administrative Expenses	24.57 Million	2.94 Million
Research and Development Expenses	68.42 Million	27.78 Million
Other Expenses	-	-
Cost and Expenses	93 Million	30.72 Million
Operating Income	-93 Million	-30.72 Million
Interest Expense	-	9.15 Million
Income Tax Expense	-	-33.52 Thousand
Earnings before Tax	-83.98 Million	-39.78 Million
Net Income	-83.98 Million	-39.78 Million
Earnings Per Share Basic	-0.00	-0.79
Earnings Per Share Diluted	-0.00	-0.79
Weighted Average Shares Outstanding	25 Billion	50.67 Million
Weighted Average Shares Outstanding (Diluted)	25 Billion	50.67 Million
Gross Margin	-	-
EBIT Margin	-	-
Profit Margin	-	-
EBITDA	-83.98 Million	-
Earnings Before Tax Margin	-	-

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	36 Thousand	29 Thousand	-	-	-	-
Gross Profit	-36 Thousand	-29 Thousand	-	-	-	-
Operating Expenses	44.08 Million	38.15 Million	37.15 Million	93 Million	24.3 Million	18.88 Million
Selling, General and Administrative Expenses	10.88 Million	9.43 Million	8.2 Million	-	7.23 Million	4.93 Million
Research and Development Expenses	33.2 Million	28.71 Million	28.95 Million	-	17.06 Million	13.94 Million
Other Expenses	-	-	-	-	-	-
Cost and Expenses	44.12 Million	38.18 Million	37.15 Million	93 Million	24.3 Million	18.88 Million
Operating Income	-44.12 Million	-38.18 Million	-37.15 Million	-93 Million	-24.3 Million	-18.88 Million
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-	-14.27 Thousand	-37.15 Thousand	-93 Thousand	3.5 Million	-18.88 Thousand
Earnings before Tax	-33.81 Million	-32.09 Million	-31.73 Million	-83.98 Million	-20.84 Million	-18.88 Million
Net Income	-33.81 Million	-32.09 Million	-31.73 Million	-83.98 Million	-20.84 Million	-18.88 Million
Earnings Per Share Basic	-0.60	-0.64	-0.63	-	-0.41	-0.40
Earnings Per Share Diluted	-0.60	-0.64	-0.63	-	-0.41	-0.40
Weighted Average Shares Outstanding	56.51 Million	50.18 Million	50.65 Million	50.65 Million	50.67 Million	47.61 Million
Weighted Average Shares Outstanding (Diluted)	56.51 Million	50.18 Million	50.65 Million	50.65 Million	50.67 Million	47.61 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-44.08 Million	-38.15 Million	-37.15 Million	-	-20.84 Million	-18.88 Million
Earnings Before Tax Margin	-	-	-	-	-	-